Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansa Qureshi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|December 9, 2008
Myfortic (mycophenolate sodium) delayed-release tabletsAnsa Qureshi, Noah Scheinfeld
European Journal of Dermatology : EJD|March 2, 2002
Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceusNaveed Sami, Ansa Qureshi, A Razzaque Ahmed
Archives of Dermatology|September 13, 2002
Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgarisNaveed Sami, Ansa Qureshi, Eleonora Ruocco, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|December 9, 2008
Myfortic (mycophenolate sodium) delayed-release tabletsAnsa Qureshi, Noah Scheinfeld
European Journal of Dermatology : EJD|March 2, 2002
Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceusNaveed Sami, Ansa Qureshi, A Razzaque Ahmed
Archives of Dermatology|September 13, 2002
Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgarisNaveed Sami, Ansa Qureshi, Eleonora Ruocco, et al.
Pageof 1